(Q40109995)

17 September 2017

1 reference

title

Interferon--present and future prospects (English)

1 reference

17 September 2017

Interferon—Present and Future Prospects (English)

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

author name string

Richtsmeier WJ

1

1 reference

17 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6202461

27 August 2023

publication date

1 January 1984

1 reference

full work available at URL

17 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/10408368409165770

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Critical Reviews in Clinical Laboratory Sciences

27 August 2023

published in

1 reference

17 September 2017

volume

20

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

57-93

1 reference

The effects of some different metabolic inhibitors on interferon superinduction

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Induction of 2′5′-oligoadenylate synthetase activity and a new protein by chick interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Nuclease activation by double-stranded RNA and by 2′,5′-oligoadenylate in extracts of interferon-treated chick cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Common pathways of interferon and hormonal action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Production and role of interferon in physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferons: Rationale for Clinical Trials in Neoplastic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Effect of prolonged administration of interferon-alpha on pharmacokinetics, fever, lymphocyte proliferative response, and NK cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon enhances the excitability of cultured neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Large-scale Production of Human Leukocyte Interferon Containing 108 Units per ml

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Pharmacokinetics of human leukocyte interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mechanism of interferon uptake in parental and somatic monkey-mouse hybrid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Role of receptors and the cytoskeleton in reverse transformation and steroidogenesis induced by interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon Production in Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inhibition of adipose conversion of BALB/c 3T3 cells by interferon and 12-O-tetradecanoylphorbol-13-acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Role of G0-G1 arrest in the inhibition of tumor cell growth by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interaction of insulin with the cell membrane: the primary action of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mode of action of the hemin-controlled inhibitor of protein synthesis: studies with factors from rabbit reticulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Clinical Trials with Exogenous Interferon: Summary of a Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mechanism of interferon action: Synthesis and activity of the interferon-mediated low-molecular-weight oligonucleotide from murine and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mengovirus-induced inhibition of cell protein synthesis and subsequent recovery of cellular activity in interferon-pretreated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon and cyclic-3'5'-adenosine monophosphate: potentiation of antiviral activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inhibition of virus-induced murine diabetes by an interferon inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inhibition of Cell Division by Interferons. Changes in the Transport and Intracellular Metabolism of Thymidine in Human Lymphoblastoid (Daudi) Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Regulation of the immune response by prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Structure of the human immune interferon gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

INTERFERON-INDUCED DISEASE IN MICE AND RATS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

The Interferons and Their Inducers: Molecular and Therapeutic Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Repression of interferon action: induced dedifferentiation of embryonic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Natural killer cells: their roles in defenses against disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Immune Interferon in the Circulation of Patients with Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

The preventive effect of human interferon-alpha preparation on upper respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Side Effects of Long-Term Treatment with Human Leukocyte Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Virus interference. I. The interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Duration of protective action of interferon against infection with West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Effect of Treatment of Mice with Sera Containing Gamma Interferon on the Course of Infection withSalmonella typhimuriumStrain LT-2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

The molecular basis of the antiviral activity of interferons: introductory remarks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Concerning the mechanism of action of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Clinical trials of topical interferon therapy of ulcerative viral keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Reversal of the interferon-induced block of protein synthesis by purified preparations of eucaryotic initiation factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Comparison of Experimental Binding Data and Theoretical Models in Proteins Containing Subunits*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Comparison of the Suppression of Cell and Virus Growth in Transformed Human Cells by Leukocyte and Fibroblast Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Transmission of hormonal stimulation by cell-to-cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon-induced transfer of viral resistance between animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon, double-stranded RNA, and protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Biochemistry of Interferons and Their Actions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Induction of an antiviral response by interferon requires thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Changes in DNA-polymerase and thymidine kinase activity during interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Effects of leukocyte and fibroblast interferon on events in the fibroblast cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon action II. Membrane-bound alkaline ribonuclease activity in chick embryo cells manifesting interferon-mediated interference

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Multiple active sites on human interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Prevention of Reactivated Herpes Simplex Infection by Human Leukocyte Interferon after Operation on the Trigeminal Root

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon effects on microfilament organization cellular fibronectin distribution, and cell motility in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon effects on the growth and division of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Spontaneous production of human interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon: An anti-cancer agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Role of interferon-induced enzymes in the antiviral and antimitogenic effects of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: translation inhibition, protein phosphorylation, and messenger RNA methylation and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mechanisms of interferon-mediated inhibition of protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: Phosphorylation of protein synthesis initiation factor eIF-2 and ribosome-associated protein P1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mechanism of interferon action: Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon: therapeutic fact or fiction for the '80s?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inhibition of interferon action by actinomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inhibitory effect of interferon on cellular DNA synthesis: modulation by pure mitogenic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Direct cytolysis by partially-purified preparations of immune interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon externalization by producing cell before induction of antiviral state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

The mechanism of inhibition of reovirus replication by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferons and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Lethality of interferon preparations for newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

21 January 2018

Interferon nomenclature

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Mode of Action of Interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368409165770

Interferon production in human hematopoietic cell lines: response to chemicals and characterization of interferons

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The kidney is the main site of interferon degradation

27 August 2023

12

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon

27 August 2023

13

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial

27 August 2023

20

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The New England Journal of Medicine

27 August 2023

21

307

1080

Borgstrom S.

1982

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

22

41

244

Bradley E. C.

1981

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro

27 August 2023

24

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Texas Reports on Biology and Medicine

27 August 2023

27

35

138

Cantell K.

1977

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Inhibitory Effect of Interferon Preparations and Inducers on the Multiplication of Transplanted Allogeneic Spleen Cells and Syngeneic Bone Marrow Cells

27 August 2023

30

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interaction of interferon, macrophage, and lymphocyte tumoricidal activity with prostaglandin effect

27 August 2023

35

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells

27 August 2023

42

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Unexpectedly rapid action of human interferon in physiological conditions

27 August 2023

46

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Kinetics of the rapid action of interferon

27 August 2023

47

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Membrane alteration responsible for the induction of gamma interferon

27 August 2023

48

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells

27 August 2023

49

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy

27 August 2023

50

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon preparations enhance phagocytosis in vivo

27 August 2023

51

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha

27 August 2023

53

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The role of infection in allergic disease.

27 August 2023

54

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Impaired interferon response of children with congenital cytomegalovirus disease

27 August 2023

55

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon-gamma: success, structure and speculation

27 August 2023

59

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon

27 August 2023

60

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Absence of functional and structural homology of natural and recombinant human leukocyte interferon (IFN-α) with human α-ACTH and β-endorphin

27 August 2023

61

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Growth-inhibitory and antiviral activity of purified leukocyte interferon

27 August 2023

64

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells

27 August 2023

65

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Large scale production of human interferon from human spleens

27 August 2023

67

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon Action: RNA Cleavage Pattern of a (2′-5′)Oligoadenylate—Dependent Endonuclease

27 August 2023

69

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

55 Cell surface alterations induced by interferon

27 August 2023

71

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon Binding: The First Step in Establishment of Antiviral Activity

27 August 2023

72

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Inhibition of arbovirus protein synthesis by interferon

27 August 2023

74

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Inhibition by interferon of thymidine uptake and deoxyribonucleic acid synthesis in human lymphoblastoid cells [proceedings]

27 August 2023

79

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The interferon dose response curve and its possible significance

27 August 2023

81

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children

27 August 2023

82

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Suppression of the Intracellular Growth of Shigella flexneri in Cell Cultures by Interferon Preparations and Polyinosinic-Polycytidylic Acid

27 August 2023

83

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Leukocyte interferon in patients with juvenile laryngeal papillomatosis

27 August 2023

84

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Inhibition of Shigella flexneri by Lysates of Cells Treated with Interferon-Containing Preparations

27 August 2023

88

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Pronounced antiviral activity of human interferon on bovine and porcine cells

27 August 2023

90

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s)

27 August 2023

96

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

27 August 2023

98

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon Therapy in Juvenile Laryngeal Papillomatosis

27 August 2023

99

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Effect of Human Nasal Secretions on the Antiviral Activity of Human Fibroblast and Leukocyte Interferon

27 August 2023

104

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Effects of Passive Transfer and Induction of Gamma (Type II Immune) Interferon Preparations on the Metabolism of Diphenylhydantoin by Murine Cytochrome P-450

27 August 2023

105

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Production of high-titered interferon in cultures of human diploid cells

27 August 2023

106

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages

27 August 2023

108

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The New England Journal of Medicine

27 August 2023

111

308

286

Hill N. O.

1983

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

Interferon

114

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The role of interferon in immediate hypersensitivity and autoimmune diseases

27 August 2023

116

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Immune reactions and long-term therapy with human leukocyte interferon

27 August 2023

123

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Radioimmunoassay for human beta interferon.

27 August 2023

125

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon standards: A memorandum

27 August 2023

128

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections

27 August 2023

130

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

A Sensitive Interferon Assay for Many Species of Cells: Encephalomyocarditis Virus Hemagglutinin Yield Reduction

27 August 2023

135

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Bluetongue virus, an exceptionally potent interferon inducer in mice

27 August 2023

136

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Production of alpha and gamma interferons by spleen cells from cytomegalovirus-infected mice

27 August 2023

145

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment

27 August 2023

146

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L 1210 cells and their position in the cell cycle

27 August 2023

149

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Mitochondrial protein synthesis is inhibited by 2'-5' linked oligoadenylic acid triphosphate

27 August 2023

152

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon inhibition of protein synthesis by isolated mitochondria

27 August 2023

153

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Ultrastructural localization of interferon receptors on the surfaces of cultured cells and erythrocytes

27 August 2023

156

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The Presence of -Interferon in Human Amniotic Fluid

27 August 2023

158

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Infective factors in exacerbations of bronchitis and asthma

27 August 2023

159

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Large-scale production and physicochemical characterization of human immune interferon

27 August 2023

161

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Antiproliferative effect of (2′–5′)oligoadenylate distinct from that of interferon in lymphoid cells

27 August 2023

164

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon induced growth depression in diploid and heteroploid human cells

27 August 2023

166

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon in biopsy and autopsy specimens of brain. Its presence in herpes simplex virus encephalitis

27 August 2023

167

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

EFFECT OF ACTINOMYCIN D AND PUROMYCIN DIHYDROCHLORIDE ON ACTION OF INTERFERON

27 August 2023

170

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Molecular basis of the action of interferon

27 August 2023

171

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells.

27 August 2023

173

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Tunicamycin Enhances the Antiviral and Anticellular Activity of Interferon

27 August 2023

176

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon and laryngeal papillomatosis. The Iowa experience

27 August 2023

181

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon--The First Quarter Century

27 August 2023

185

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon

27 August 2023

186

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

191

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

192

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by Mycobacterium bovis BCG cell wall fraction in Mycobacterium bovis BCG-sensitized mice

27 August 2023

193

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model

27 August 2023

194

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Detection of gamma interferon in the sera of patients with Behçet's disease

27 August 2023

196

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Toxic Effects of Interferon

27 August 2023

198

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor

27 August 2023

202

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Effects of interferon-alpha on human warts

27 August 2023

205

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon modulation of natural killer cell activity

27 August 2023

206

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Spontaneous production of T (type II) interferon by a murine reticulum-cell sarcoma

27 August 2023

210

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

27 August 2023

213

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Neurovirulence Mutant of Vesicular Stomatitis Virus with an Altered Target Cell Tropism In Vivo

27 August 2023

214

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

216

43

940

Quesada J. R.

1983

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation

27 August 2023

217

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Human lupus inclusions and interferon

27 August 2023

220

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Inhibition of natural killer cell activity in vitro by alcohols

27 August 2023

225

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interactions of interferon with in vitro model systems involved in hematopoietic cell differentiation

27 August 2023

227

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Convenient assay for interferons

27 August 2023

228

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Cellular interactions in the augmentation of human NK activity by interferon

27 August 2023

229

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

A protein synthesizing system from interferon-treated cells that discriminates between cellular and viral messenger RNAs

27 August 2023

231

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon inhibition of hexose monophosphate shunt activity as the mechanism of blocking differentiation of a preadipose cell line

27 August 2023

236

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases

27 August 2023

239

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Monitoring of Interferon Therapy by Assay of (2′-5′) Oligo-Isoadenylate Synthetase in Human Peripheral White Blood Cells

27 August 2023

240

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Treatment of Juvenile Laryngeal Papillomatosis with Two Types of Interferon

27 August 2023

241

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferons and Bronchogenic Carcinoma in Juvenile Laryngeal Papillomatosis

27 August 2023

242

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Systemic IFN-alpha treatment of multiple bladder papilloma grade I or II patients: pilot study

27 August 2023

243

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

Toxicity of interferon.

244

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli

27 August 2023

246

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

Toxicity of interferon.

247

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

27 August 2023

248

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The Neuraminidase Yield-Reduction Bioassay of Human and Other Interferons

27 August 2023

249

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Further heterogeneity of human alpha interferon mRNA species

27 August 2023

250

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation

27 August 2023

255

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

50 Antiproliferative assay for human interferons

27 August 2023

256

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Neurological effects of recombinant human interferon

27 August 2023

257

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Increased Serum Levels of an Interferon-Like Activity during the Acute Period of Experimental Infection with Different Strains of Trypanosoma Cruzi *

27 August 2023

260

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer

27 August 2023

261

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

UCLA conference. Interferon: immunobiology and clinical significance

27 August 2023

262

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

PATTERNS OF INTERFERON APPEARANCE IN MICE INFECTED WITH BACTERIA OR BACTERIAL ENDOTOXIN.

27 August 2023

263

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Combination therapy of dendritic keratitis with trifluorothymidine and interferon

27 August 2023

266

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

267

1186

Sundmacher A.

1976

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Tumor Suppression with a Combination of α-Difluoromethyl Ornithine and Interferon

27 August 2023

268

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

High-yield interferon induction by 10-carboxymethyl-9-acridanone in mice and hamsters

27 August 2023

273

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

274

40

2919

Tomida M.

1980

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Successful treatment of nasopharyngeal carcinoma with interferon

27 August 2023

275

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Tumour cell lines induce interferon in human lymphocytes

27 August 2023

277

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Interferon as a Cell Product

27 August 2023

285

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Annals of the New York Academy of Sciences

27 August 2023

286

350

13

Vilcik J.

1980

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study

27 August 2023

290

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Immunological properties of thymus cell subpopulations: rat thymic dendritic cells are potent accessory cells and stimulators in a mixed leukocyte culture

27 August 2023

291

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Exogenous Interferon Administration in Experimental Leishmaniasis: In Vivo and in Vitro Studies

27 August 2023

292

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I)-poly(C) and human interferon

27 August 2023

294

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

Serum interferon levels in patients with systemic lupus erythematosus

27 August 2023

295

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

The Role of Interferon in the Resistance of CS7BL/6 Mice to Various Doses of Herpes Simplex Virus Type 1

27 August 2023

296

1 reference

https://api.crossref.org/works/10.3109/10408368409165770

27 August 2023

Identifiers

1 reference

17 September 2017

1 reference